Design Novel Dual Agonists for Treating Type-2 Diabetes by Targeting Peroxisome Proliferator-Activated Receptors With Core Hopping Approach

PLoS ONE - United States
doi 10.1371/journal.pone.0038546
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Targeting Peroxisome Proliferator-Activated Receptors Using Thiazolidinediones: Strategy for Design of Novel Antidiabetic Drugs

International Journal of Medicinal Chemistry
BiochemistryDrug DiscoveryMolecular Medicine
2017English

Design and Synthesis of Dual Peroxisome Proliferator-Activated Receptors G and D Agonists as Novel Euglycemic Agents With a Reduced Weight Gain Profile

English

Peroxisome Proliferator-Activated Receptors (PPAR)γ Agonists as Master Modulators of Tumor Tissue

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2018English

Drugs and the Peroxisome Proliferator Activated Receptors

2014English

Peroxisome Proliferator-Activated Receptor Gamma Agonists in Renal Disease

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2006English

Regulation of Peroxisome Proliferator-Activated Receptors by E6-Associated Protein

PPAR Research
Drug DiscoveryPharmacology
2008English

Peroxisome Proliferator-Activated Receptors and Hepatitis C Virus

Therapeutic Advances in Gastroenterology
Gastroenterology
2011English

Peroxisome Proliferator-Activated Receptors in HCV-Related Infection

PPAR Research
Drug DiscoveryPharmacology
2009English

Peroxisome Proliferator-Activated Receptors Associated With Nonalcoholic Fatty Liver Disease

PPAR Research
Drug DiscoveryPharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy